| Literature DB >> 30342581 |
Niharika Rath1, Nikita Raje1, Lanny Rosenwasser2.
Abstract
Asthma is a chronic disease that affects children and adults with significant morbidity and mortality. It is multifactorial, with genetic and environmental factors affecting the overall course of the disease. Both specific and total immunoglobulin (Ig)E can be used in specific phenotypes such as allergic asthma. Using IgE as a biomarker for asthma provides a target for management and treatment. Biotherapeutics continue to emerge as important advances in asthma treatment, and their effect on IgE and its biomarker role continue to be studied.Entities:
Keywords: Asthma; Biomarker; Biotherapy; IgE
Mesh:
Substances:
Year: 2018 PMID: 30342581 DOI: 10.1016/j.iac.2018.06.007
Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN: 0889-8561 Impact factor: 3.479